A post-marketing surveillance study of a human live-virus pandemic influenza A (H1N1) vaccine (Nasovac®) in India

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 1, 2013, Pages 122-124

  Kulkarni, Prasad S ^a   Raut, Sidram K ^b   Dhere, Rajeev M ^a  

^a Serum Institute of India Ltd   (India)

^b Nobel Hospital   (India)

Author keywords

Live attenuated; Pandemic H1N1 vaccine; Post marketing surveillance

Indexed keywords

CHLORPHENIRAMINE MALEATE; CODEINE; IBUPROFEN; LIVE VACCINE; PARACETAMOL; PHENYLEPHRINE; SWINE INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANOREXIA; ARTHRALGIA; ARTICLE; CHILD; CHILL; CONTROLLED STUDY; COUGHING; DIARRHEA; DISEASE TRANSMISSION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; EPIDEMIC; FATIGUE; FEMALE; HEADACHE; HUMAN; INCIDENCE; INDIA; INFLUENZA VIRUS A H1N1; IRRITABILITY; LACRIMATION; MALE; MYALGIA; NAUSEA; NOSE DISEASE; PANDEMIC INFLUENZA; POSTMARKETING SURVEILLANCE; PRESCHOOL CHILD; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RHINORRHEA; SCHOOL CHILD; SIDE EFFECT; SMELLING DISORDER; SNEEZING; SORE THROAT; WHEEZING;

ADMINISTRATION, INTRANASAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DRUG TOXICITY; FEMALE; HUMANS; INDIA; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING; RETROSPECTIVE STUDIES; VACCINES, ATTENUATED; YOUNG ADULT;

EID: 84874742439     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22317     Document Type: Article

References (13)

1. Centers for Disease Control and Prevention (CDC). Outbreak of swine-origin influenza A (H1N1) virus infection -Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009; 58:467-70; PMID:19444150.
2. World Health Organization. Pandemic (H1N1) 2009 -update 69. http://www.who.int/csr/don/2009-10-09/en/index.html (Accessed October 13, 2009).
3. World Health Organization. World now at the start of 2009 influenza pandemic. http://www.who.int/mediacentre/news/statements/2009/h1n1-pandemic- phase6-20090611/en/index.html (Accessed June 11, 2009).
4. Ministry of Health and Family Welfare, Government of India: Update of influenza A (H1N1) as on 17th May, 2009. Press release dated 17th May, 2009: http://pib. nic.in/newsite/erelease.aspx?relid=48762 (Accessed on 15 March 2011).
5. Mishra AC, Chadha MS, Choudhary ML, Potdar VA. Pandemic influenza (H1N1) 2009 is associated with severe disease in India. PLoS One 2010; 5:e10540; PMID:20479875; http://dx.doi.org/10.1371/journal.pone.0010540.
6. http://mohfw-h1n1.nic.in/documents/PDF/SituationalUpdatesArchives/ december2010/Situational%20Updates%20on%2027.12.2010.pdf [accessed on 15 March 2011]
7. http://mohfw-h1n1.nic.in/Epidemiological.html
8. http://www.who.int/csr/disease/swineflu/notes/h1n1- vaccine-20090713/en/ index.html. (Accessed October 18, 2009).
9. Dhere R, Yeolekar L, Kulkarni P, Menon R, Vaidya V, Ganguly M, et al. A pandemic influenza vaccine in India: from strain to sale within 12 months. Vaccine 2011; 29(Suppl 1):A16-21; PMID:21684421; http://dx.doi.org/10.1016/j. vaccine.2011.04.119.
10. Beyer WE, Palache AM, de Jong JC, Osterhaus AD. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. Vaccine 2002; 20:1340-53; PMID:11818152; http://dx.doi.org/10.1016/S0264-410X(01)00471- 6.
11. Hassan E. Recall Bias can be a Threat to Retrospective and Prospective Research Designs. Int J Epidemiol 2006; 3:26.
12. Margetts B, Vorster H, Venter C. Evidence-based nutrition: the impact of information and selection bias on the interpretation of individual studies. South African Journal of Clinical Nutrition 2003; 16:78-87.
13. Bradburn N, Rips L, Shevell S. Answering autobiographical questions: The impact of memory and inference on surveys. Science. New Series 1987; 236:157-61.